Clinical Trial Update: Effect of SGLT2 Inhibition on OCT-A Parameters in Diabetic CKD [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of SGLT2 inhibition on OCT-A parameters in diabetic kidney and retinal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Diseases
• Diabetes Mellitus
• Diabetic Retinopathy

Snippet

Sponsor: National University of Malaysia | Conditions: Diabetic Retinopathy, Chronic Kidney Diseases | Phase 4 | Status: UNKNOWN